Research and Markets: 2014 Strategies for the US Nucleic Acid Testing MarketThe Herald | HeraldOnline.com (press release)Infectious Diseases – Cancer – Forensic Testing – Genetic Diseases – Paternity Testing/HLA Typing Review of testing methodologies a…
Research and Markets: Strategies for the European Hematology and Flow …The Herald | HeraldOnline.com (press release)Cell Surface Markers (CD4/CD8/T&B Lymphocytes, CD34, Others), Chemotherapy Monitoring (Leukemia/Lymphoma, Others), HLA Typing, Spe…
Research and Markets: Strategies for the European Hematology and Flow …Fort Mills TimesCell Surface Markers (CD4/CD8/T&B Lymphocytes, CD34, Others), Chemotherapy Monitoring (Leukemia/Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinet…
Global Molecular Diagnostics Market Expected to Reach USD 8.7 Billion in 2019Midland Daily NewsOncology testing and HLA typing testing are also projected to grow at a rapid rate during the same forecast period. Technology wise, PCR accounts for the lar…
Global Molecular Diagnostics Market Expected to Reach USD 8.7 Billion in 2019PR Web (press release)Oncology testing and HLA typing testing are also projected to grow at a rapid rate during the same forecast period. Technology wise, PCR accounts for the…
|
CHOP Introduces HLA Typing by Next-Generation Sequencing to Its Clinical …
PR Web (press release) CHOP is the first hospital anywhere to offer this new comprehensive HLA-typing test, based on extensive research by Monos and colleagues. “This is a new, disruptive technology, with the potential to transform research and clinical practice, in … |
Illumina Expands in China – Analyst BlogNASDAQFurther, Illumina is set to enter emerging markets – its third focus area – where it plans to launch a human leukocyte antigen (HLA) typing product in mid-2014. Additionally, the company introduced the MiSe…
|
Illumina Expands in China
Zacks.com Further, Illumina is set to enter emerging markets – its third focus area – where it plans to launch a human leukocyte antigen (HLA) typing product in mid-2014. Additionally, the company introduced the MiSeq Forensic Genomics System (MiSeq FGx), the … |
Research and Markets: Strategies for the United States Coagulation Testing …The Herald | HeraldOnline.com (press release)Cell Surface Markers (CD4/CD8/T&B Lymphocytes, CD34, Others), Chemotherapy Monitoring (Leukemia/Lymphoma, Others), HLA Typing…
|
CHOP develops unique laboratory test to characterize genes that encode HLA …
News-Medical.net CHOP is the first hospital anywhere to offer this new comprehensive HLA-typing test, based on extensive research by Monos and colleagues. “This is a new, disruptive technology, with the potential to transform research and clinical practice, in … |